For a patient with an average daily insulin requirement of 29.5 units on pump therapy, should the initial insulin glargine (Lantus) dose be roughly half of that (≈14–15 units) once daily?

No, do not use half the pump dose when converting to Lantus

When transitioning from insulin pump therapy (29.5 units/day total daily dose) to insulin glargine (Lantus), the recommended initial dose is approximately one-third of the total daily insulin requirement for type 1 diabetes, NOT half. 1

Conversion Algorithm

For Type 1 Diabetes (Most Likely Scenario for Pump Users):

Starting Lantus dose = approximately 1/3 of total daily insulin (TDI) from pump

• With 29.5 units TDI on pump: Start Lantus at ~10 units once daily
• The remaining 2/3 of insulin needs must be covered with rapid-acting insulin before meals 1
• This means approximately 20 units of rapid-acting insulin divided across meals

For Type 2 Diabetes (Less Common for Pump Users):

If this were a type 2 diabetes patient (unlikely on pump), guidelines recommend:

• Start 10 units once daily OR 0.1-0.2 units/kg/day 2
• This aligns with the one-third rule above

Critical Safety Considerations

Why NOT half the dose?

1. The FDA label explicitly states that for type 1 diabetes, Lantus should be approximately one-third of TDI, with short-acting insulin covering the remainder 1

2. Using half (14-15 units) would be excessive for basal coverage alone and could cause:

   • Hypoglycemia risk, especially overnight
   • Inadequate prandial coverage if not properly supplemented
   • "Over-basalization" with poor postprandial control 2

3. Hospital conversion guidelines recommend 80% of total NPH dose when converting from twice-daily NPH, but this is a different scenario than pump conversion 3

Titration Strategy

After starting at ~10 units:

• Increase by 2 units every 3 days to reach fasting glucose goal 2
• Monitor for hypoglycemia; if occurs without clear cause, reduce dose by 10-20% 2
• Adjust rapid-acting insulin separately for meal coverage

Common Pitfall to Avoid

Do not simply divide the pump TDI in half for Lantus dosing. This oversimplifies the conversion and ignores that:

• Pump therapy delivers continuous basal insulin (typically 40-50% of TDI) plus boluses
• Lantus provides only basal coverage
• The pharmacokinetics differ significantly between pump delivery and once-daily injection 1

The one-third rule for basal insulin in type 1 diabetes is evidence-based and FDA-approved, ensuring adequate basal coverage while maintaining safety margins for hypoglycemia prevention.